This complimentary program is geared toward U.S. companies expanding or starting business in China as well as U.S. private equity funds looking to expand their investment portfolios by acquiring equity interests in Chinese companies.
During this interactive session, panelists will discuss the common pitfalls of and practical strategies for doing business in China, including:
- Current trends impacting U.S. companies investing and doing business in China
- Special issues involved in acquiring equity interests in Chinese companies
- China’s foreign exchange control regulations and what they mean to U.S. companies in China
- Considerations on capital structure and available financing options for investments in China
- Managing employer-employee relationships in China
- Challenges of and opportunities arising from the current economic situations in the United States and China
Featured Speakers:
- H. Timothy Lopez, A.O. Smith, Associate General Counsel
- Kok-Chi Tsim, JPMorgan Chase, Managing Director and Senior Relationship Executive
- Z. Julie Lee, Foley International Business Transactions Partner
- Barry L. Grossman (Moderator), Foley Intellectual Property Of Counsel
Co-Sponsor:

People
Related Insights
December 22, 2025
Foley Viewpoints
Guyana: A Primer on a Strategic U.S. Caribbean & South American Ally
Guyana does not currently have a binding corporate governance code, and minority shareholder protections are relatively weak. Foreign investors must therefore structure joint ventures and other partnerships carefully, using shareholder agreements, board representation rights, and dispute resolution clauses to safeguard their interests.
December 19, 2025
Health Care Law Today
Gender-Affirming Care for Minors: CMS and HHS Propose Limits on “Sex Rejection Procedures” and Expanded Enforcement Pathways
On December 18, 2025, the U.S. Department of Health and Human Services (HHS) held a press conference focused on what is defined as “sex…
December 19, 2025
Foley Viewpoints
Prohibition to Prescription: What Trump’s Marijuana Executive Order Really Means
On December 18, 2025, President Donald Trump issued an Executive Order, Increasing Medical Marijuana and Cannabidiol Research, that…